National Vision (EYE) Form 4: Naomi Kelman Granted 7,392 RSUs
Rhea-AI Filing Summary
National Vision Holdings (EYE) – Form 4 filing overview: On 06/18/2025, independent director Naomi Kelman received an equity award of 7,392 restricted stock units (RSUs), each convertible into one share of common stock. The RSUs were granted at $0 cost and will vest in full on the first anniversary of the grant date, subject to continued service. Following the award, Kelman’s total direct beneficial ownership increased to 41,041 shares.
No shares were sold and no cash was exchanged, indicating the transaction is a routine annual equity grant designed to align director incentives with shareholder interests. No derivative positions or additional transactions were reported.
Positive
- 7,392 RSUs granted to director Naomi Kelman increase insider equity stake to 41,041 shares, modestly enhancing management–shareholder alignment.
Negative
- None.
Insights
TL;DR: Routine director RSU grant; minimal market impact.
The 7,392-share RSU award to Director Kelman represents roughly 0.01% of EYE’s 79 million share float—too small to influence supply-demand dynamics. Because the grant is contingent and cost-free, it does not signal insider sentiment such as active buying. Nonetheless, the award modestly strengthens long-term incentive alignment. I view the filing as neutral for valuation or liquidity considerations.
TL;DR: Standard annual equity compensation; supports alignment.
Annual RSU grants to non-employee directors are common in S&P 600 governance practices. Vesting after one year encourages at least a short holding period and helps satisfy ownership guidelines. No red flags—no accelerated vesting, no options backdating, and the grant size is consistent with peer medians. Impact on governance risk profile is neutral to slightly positive.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,392 | $0.00 | -- |
Footnotes (1)
- [object Object]